Global Polymeric Bioabsorbable Stents Market Growth (Status and Outlook) 2024-2030

Global Polymeric Bioabsorbable Stents Market Growth (Status and Outlook) 2024-2030

A stent is a medical device which is inserted into the internal duct of the body for expanding the blood vessels and preventing the vessels from blockage. Bioabsorbable stents, also known as bioresorbable stents or naturally-dissolving stents, are made up of materials that get absorbed in the body and act by expanding the vessels or internal duct for clearing the blockage caused due to the deposition of plague. These devices are designed in such a way that after eluting the drug, the stents gets dissolved within the body at certain interval of time. Research is still conducted on polymeric stent materials for the development of the novel bioabsorbable stents, which possess low risk for restenosis and late-stent thrombosis.

The global Polymeric Bioabsorbable Stents market size is projected to grow from US$ 123 million in 2024 to US$ 209 million in 2030; it is expected to grow at a CAGR of 9.2% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Polymeric Bioabsorbable Stents Industry Forecast” looks at past sales and reviews total world Polymeric Bioabsorbable Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Polymeric Bioabsorbable Stents sales for 2023 through 2029. With Polymeric Bioabsorbable Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymeric Bioabsorbable Stents industry.

This Insight Report provides a comprehensive analysis of the global Polymeric Bioabsorbable Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Polymeric Bioabsorbable Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polymeric Bioabsorbable Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymeric Bioabsorbable Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymeric Bioabsorbable Stents.

Increase in geriatric population, rise in prevalence of cardiovascular disease, surge in percutaneous coronary intervention (PCI) procedure, and rise in adaptation of bioabsorbable stent by patients and physicians are the key factors that drive the growth of the global bioabsorbable stents market. In addition advancement in technology in stents, growth in demand for minimally invasive procedures, and increase in initiative taken by government for development & production of bioabsorbable stents propel the growth of the market.

This report presents a comprehensive overview, market shares, and growth opportunities of Polymeric Bioabsorbable Stents market by product type, application, key players and key regions and countries.

Segmentation by Type:
Coronary Artery Stents
Peripheral Artery Stents

Segmentation by Application:
Hospitals
Cardiac Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Coronary Artery Stents
Peripheral Artery Stents

Segmentation by Application:
Hospitals
Cardiac Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation
Biotronik Se & Co. Kg
B. Braun Melsungen Ag
Reva Medical, Inc
Arterius Limited
Microport Scientific Corporation
Kyoto Medical Planning Co. Ltd
Terumo Corporation
Arterial Remodeling Technologies
Elixir Medical Corporation
Abbott Vascular

Please note: The report will take approximately 2 business days to prepare and deliver.